Evidence map›Paper›PMID 23555655›Full record

ArticlePloS one2013

Molecular study of dietary heptadecane for the anti-inflammatory modulation of NF-kB in the aged kidney.

Dae Hyun Kim, Min Hi Park, Yeon Ja Choi, Ki Wung Chung, Chan Hum Park, Eun Ji Jang, Hye Jin An, Byung Pal Yu, Hae Young Chung

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. SpirulinaLife (Basel, Switzerland) · 2024
    Review
  7. Article
  8. RSC advances · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Network pharmacology andAnnals of medicine · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Dae Hyun KimDepartment of Pharmacy, College of Pharmacy, Aging Tissue Bank, Pusan National University, Busan, Republic of Korea.
Min Hi Park
Yeon Ja Choi
Ki Wung Chung
Chan Hum Park
Eun Ji Jang
Hye Jin An
Byung Pal Yu
Hae Young Chung
Pusan National University · KRThe University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heptadecane is a volatile component of Spirulina platensis, and blocks the de novo synthesis of fatty acids and ameliorates several oxidative stress-related diseases. In a redox state disrupted by oxidative stress, pro-inflammatory genes are upregulated by the activation of NF-kB via diverse kinases. Thus, the search and characterization of new substances that modulate NF-kB are lively research topics. In the present study, heptadecane was examined in terms of its ability to suppress inflammatory NF-kB activation via redox-related NIK/IKK and MAPKs pathway in aged rats. In the first part of the study, Fischer 344 rats, aged 9 and 20 months, were administered on average approximately 20 or 40 mg/Kg body weight over 10 days. The potency of heptadecane was investigated by examining its ability to suppress the gene expressions of COX-2 and iNOS (both NF-κB-related genes) and reactive species (RS) production in aged kidney tissue. In the second part of the study, YPEN-1 cells (an endothelial cell line) were used to explore the molecular mechanism underlying the anti-inflammatory effect of heptadecane by examining its modulation of NF-kB and NF-kB signal pathway. Results showed that heptadecane exhibited a potent anti-oxidative effect by protecting YPEN-1 cells from tert-butylhydroperoxide induced oxidative stress. Further molecular investigations revealed that heptadecane attenuated RS-induced NF-kB via the NIK/IKK and MAPKs pathways in YPEN-1 cells and aged kidney tissues. Based on these results, we conclude that heptadecane suppresses age-related increases in pro-inflammatory gene expressions by reducing NF-kB activity by upregulating the NIK/IKK and MAPKs pathways induced by RS. These findings provide molecular insight of the mechanisms by which heptadecane exerts its antiinflammatory effect in aged kidney tissues. We conclude that heptadecane suppresses age-related increases in pro-inflammatory gene expressions then travel upstream set by step by reducing NF-kB activity by downregulating the NIK/IKK and MAPKs pathways induced by RS.

Indexed as

AgingAlkanesAnimalsAnti-Inflammatory AgentsCell LineCyclooxygenase 2Endothelial CellsGene Expression RegulationI-kappa B KinaseKidneyMaleNF-kappa BNF-kappaB-Inducing KinaseNitric Oxide Synthase Type IIOxidative StressProtein Serine-Threonine KinasesAlkanesAnti-Inflammatory AgentsCyclooxygenase 2heptadecaneI-kappa B KinaseNF-kappa BNF-kappaB-Inducing KinaseNitric Oxide Synthase Type IINos2 protein, ratProtein Serine-Threonine KinasesPtgs2 protein, rattert-Butylhydroperoxide

Identifiers

PMID23555655
PMCPMC3608635
OpenAlexW2032688774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.